| Annie Mannancheril, | |
|
9114 Waukegan Rd, Morton Grove, IL 60053-2135 | |
| (000) 000-0000 | |
| Not Available |
| Full Name | Annie Mannancheril |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 4 Years |
| Location | 9114 Waukegan Rd, Morton Grove, Illinois |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306450424 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | 025541 (New York) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Divinity Medical Services Pllc | 5193030245 | 80 |
News Archive
In the first study of its kind, researchers at Saint Louis University have demonstrated that immunization with a new vaccine could potentially prevent more than a million cases of pertussis (whooping cough) each year in adolescents and adults.
InVivo Therapeutics Corporation, a company focused on the development of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today announced that it has signed a lease to open its first manufacturing and development facility in Medford, Massachusetts. The company expects to use this new facility to scale up the manufacturing process for its lead product candidate, a novel biocompatible polymer scaffolding device used to treat acute open-wound SCI.
A combination of two types of blood pressure-lowering drugs, an angiotensin-converting enzyme inhibitor (ACEI) plus an angiotensin-receptor blocker (ARB), added to enzyme replacement therapy (ERT) with agalsidase-beta (Fabrazyme, Genzyme Corporation, Cambridge, MA) is the first treatment shown to stop progressive loss of kidney function in patients with severe kidney involvement due to the rare genetic disorder Fabry disease, reports a study in the September Journal of the American Society of Nephrology.
In a study appearing online on July 7 in advance of print publication of the August 1 issue of the Journal of Clinical Investigation, Armin Schneider and colleagues from Axaron Biosciences describe new roles for granulocyte colony-stimulating factor (G-CSF) in treating stroke and other central nervous system roles of this protein.
Motor neurone disease (MND), also known as amyotrophic lateral sclerosis, is a degenerative disease of unknown cause which causes patients to lose basic motor functions and has a devastating effect on them and their families.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Annie Mannancheril, 9114 Waukegan Rd, Morton Grove, IL 60053-2135 Ph: (847) 722-7321 | Annie Mannancheril, 9114 Waukegan Rd, Morton Grove, IL 60053-2135 Ph: (000) 000-0000 |
News Archive
In the first study of its kind, researchers at Saint Louis University have demonstrated that immunization with a new vaccine could potentially prevent more than a million cases of pertussis (whooping cough) each year in adolescents and adults.
InVivo Therapeutics Corporation, a company focused on the development of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today announced that it has signed a lease to open its first manufacturing and development facility in Medford, Massachusetts. The company expects to use this new facility to scale up the manufacturing process for its lead product candidate, a novel biocompatible polymer scaffolding device used to treat acute open-wound SCI.
A combination of two types of blood pressure-lowering drugs, an angiotensin-converting enzyme inhibitor (ACEI) plus an angiotensin-receptor blocker (ARB), added to enzyme replacement therapy (ERT) with agalsidase-beta (Fabrazyme, Genzyme Corporation, Cambridge, MA) is the first treatment shown to stop progressive loss of kidney function in patients with severe kidney involvement due to the rare genetic disorder Fabry disease, reports a study in the September Journal of the American Society of Nephrology.
In a study appearing online on July 7 in advance of print publication of the August 1 issue of the Journal of Clinical Investigation, Armin Schneider and colleagues from Axaron Biosciences describe new roles for granulocyte colony-stimulating factor (G-CSF) in treating stroke and other central nervous system roles of this protein.
Motor neurone disease (MND), also known as amyotrophic lateral sclerosis, is a degenerative disease of unknown cause which causes patients to lose basic motor functions and has a devastating effect on them and their families.
› Verified 7 days ago
Kelly Pjevcevic, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 9000 Waukegan Rd, Suite 200, Morton Grove, IL 60053 Phone: 847-324-3976 | |
Clifton Howard, PA Physician Assistant Medicare: Medicare Enrolled Practice Location: 9000 Waukegan Rd, Suite 200, Morton Grove, IL 60053 Phone: 847-375-3000 | |
Patrick Knott, PA Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 9000 Waukegan Rd, Suite 200, Morton Grove, IL 60053 Phone: 847-375-3000 | |
Justine Vogel, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 9000 Waukegan Rd Ste 200, Morton Grove, IL 60053 Phone: 847-375-3000 | |
Jessica Pezzo, Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 9000 Waukegan Rd, Suite 200, Morton Grove, IL 60053 Phone: 847-375-3000 | |
Amanda Andrews, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 9000 Waukegan Rd, Suite 200, Morton Grove, IL 60053 Phone: 847-375-3000 | |
Julia Masia, Physician Assistant Medicare: Medicare Enrolled Practice Location: 9000 Waukegan Rd Ste 200, Morton Grove, IL 60053 Phone: 847-375-3000 |